HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

BACKGROUND: HER2 and TOP2A parameters (gene status, mRNA and protein expression) have individually been associated with the outcome of patients treated with anthracyclines. The aim of this study was to comprehensively evaluate the prognostic/predictive significance of the above parameters in early,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fountzilas, George, Valavanis, Christos, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Kalogeras, Konstantine T, Tzaida, Olympia, Batistatou, Anna, Kronenwett, Ralf, Wirtz, Ralph M, Bobos, Mattheos, Timotheadou, Eleni, Soupos, Nikolaos, Pentheroudakis, George, Gogas, Helen, Vlachodimitropoulos, Dimitrios, Polychronidou, Genovefa, Aravantinos, Gerasimos, Koutras, Angelos, Christodoulou, Christos, Pectasides, Dimitrios, Arapantoni, Petroula
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3275536/
https://ncbi.nlm.nih.gov/pubmed/22240029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados